Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Atrial Fibrillation and CYP2D6[original query] |
|---|
| Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors. Journal of clinical pharmacology 2009 Jan 49 (1): 17-29. Mao Zhongping L, Wheeler Jeffery J, Clohs Lilian, Beatch Gregory N, Keirns Jam |
| Population pharmacokinetics of vernakalant hydrochloride injection (RSD1235) in patients with atrial fibrillation or atrial flutter. Journal of clinical pharmacology 2012 Jul 52 (7): 1042-53. Mao Zhongping Lily, Townsend Robert W, Gao Yuying, Wheeler Jeffrey J, Kastrissios Helen, Keirns Jam |
| Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3K? inhibitor therapy. Blood 2020 12 137 (20): 2817-2826. Mato Anthony R, Ghosh Nilanjan, Schuster Stephen J, Lamanna Nicole, Pagel John M, Flinn Ian W, Barrientos Jacqueline C, Rai Kanti R, Reeves James A, Cheson Bruce D, Barr Paul M, Kambhampati Suman, Lansigan Frederick, Pu Jeffrey J, Skarbnik Alan P, Roeker Lindsey, Fonseca Gustavo A, Sitlinger Andrea, Hamadeh Issam S, Dorsey Colleen, LaRatta Nicole, Weissbrot Hanna, Luning Prak Eline T, Tsao Patricia, Paskalis Dana, Sportelli Peter, Miskin Hari P, Weiss Michael S, Svoboda Jakub, Brander Danielle |
| Diltiazem efficacy and CYP2D6 gene polymorphism in patients with atrial fibrillation with rapid ventricular response. The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology 2023 6 75 (1): 50. Mehmet Uluturk, Atakan Yilmaz, Murat Seyit, Mert Ozen, Alten Oskay, Aykut Kemanci, Medine Unal, Hande Senol, Aylin Koseler, Ibrahim Turkcu |
- Page last reviewed:Feb 1, 2024
- Content source: